Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Diabetes Reviews
  4. Volume 21, Issue 2
  5. Article
Volume 21, Issue 2
  • ISSN: 1573-3998
  • E-ISSN: 1875-6417

Abstract

Background

Diabetic Peripheral Neuropathy (DPN) is a chronic complication in Type 2 Diabetes Mellitus (T2DM) patients and is characterized by paresthesia, pain, and hypoesthesia of the extremities. The Diabetic Neuropathy Symptom-Score (DNS) is a quick, inexpensive, and easy-to-perform tool to detect DPN in clinical practice. Biochemical markers like Nitric Oxide (NO) and Vascular Endothelial Growth Factor (VEGF) play a role in the early detection of DPN. This study aims to investigate the relationship between risk factors and these biomarkers. So, it is expected to improve the prevention and treatment of diabetic neuropathy more effectively.

Methods

A cross-sectional method was used for this study. The sample size was 85 patients with T2DM who visited several primary healthcare in Medan, selected by consecutive sampling method based on eligibility criteria. Data collected included DNS, assessment of NO, VEGF, Glycated Hemoglobin (HbA1c), plasma blood glucose (PBG), and lipid profile. The collected data were analyzed using an independent T-test.

Results

The results showed that most T2DM patients, namely 73 people (85.9%), experienced DPN. From the bivariate analysis results, the risk factors associated with the prevalence of DPN in T2DM patients were found to be increased levels of total cholesterol, HbA1c, NO, and VEGF ( < 0.05). Meanwhile, blood pressure, fasting BGL, HDL-C, LDL-C, and triglycerides were not related to the occurrence of DPN in this study (> 0.05).

Conclusion

DNS can be used as a quick and easy initial screening tool implemented in clinical practice for screening DPN. Diabetic patients with DPN tend to have lower NO and increased VEGF; besides, NO levels are also associated with the progression of DPN. Furthermore, education, blood sugar control, and physical exercise, especially leg exercises, can prevent progressive DPN.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cdr/10.2174/0115733998297210240325062747
2024-03-28
2024-11-19

  • From This Site

    /content/journals/cdr/10.2174/0115733998297210240325062747
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. KhanM.A.B. HashimM.J. KingJ.K. GovenderR.D. MustafaH. Al KaabiJ. Epidemiology of Type 2 diabetes - Global burden of disease and forecasted trends.J. Epidemiol. Glob. Health201910110711110.2991/jegh.k.191028.001 32175717
     [Google Scholar]
  2. FeldmanE.L. CallaghanB.C. Pop-BusuiR. Diabetic neuropathy.Nat. Rev. Dis. Primers2019514110.1038/s41572‑019‑0092‑1 31197153
     [Google Scholar]
  3. SchreiberA.K. NonesC.F. ReisR.C. ChichorroJ.G. CunhaJ.M. Diabetic neuropathic pain: Physiopathology and treatment.World J. Diabetes20156343244410.4239/wjd.v6.i3.432 25897354
     [Google Scholar]
  4. BraffettB.H. Gubitosi-KlugR.A. AlbersJ.W. Risk Factors for Diabetic Peripheral Neuropathy and Cardiovascular Autonomic Neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.Diabetes20206951000101010.2337/db19‑1046 32051148
     [Google Scholar]
  5. Śliwińska-MossońM. MilnerowiczH. The impact of smoking on the development of diabetes and its complications.Diab. Vasc. Dis. Res.201714426527610.1177/1479164117701876 28393534
     [Google Scholar]
  6. CarmichaelJ. FadaviH. IshibashiF. ShoreA.C. TavakoliM. Advances in Screening, Early Diagnosis and Accurate Staging of Diabetic Neuropathy.Front. Endocrinol. (Lausanne)20211267125710.3389/fendo.2021.671257 34122344
     [Google Scholar]
  7. PhulpotoJ.A. GurbakhshaniK.M. ShaikhA. Role of bedside methods in evaluation of diabetic peripheral neuropathy.Rawal Med. J.201237137141
     [Google Scholar]
  8. MeijerJ.W. van SonderenE. BlaauwwiekelE.E. Diabetic neuropathy examination: a hierarchical scoring system to diagnose distal polyneuropathy in diabetes.Diabetes Care200023675075310.2337/diacare.23.6.750 10840990
     [Google Scholar]
  9. ChaD.R. KangY.S. HanS.Y. Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats.J. Endocrinol.2004183118319410.1677/joe.1.05647 15525586
     [Google Scholar]
  10. WaltonD.M. MintonS.D. CookA.D. The potential of transdermal nitric oxide treatment for diabetic peripheral neuropathy and diabetic foot ulcers.Diabetes Metab. Syndr.20191353053305610.1016/j.dsx.2018.07.003 30030157
     [Google Scholar]
  11. NordströmA. HadréviJ. OlssonT. FranksP.W. NordströmP. Higher prevalence of type 2 diabetes in men than in women is associated with differences in visceral fat mass.J. Clin. Endocrinol. Metab.2016101103740374610.1210/jc.2016‑1915 27490920
     [Google Scholar]
  12. Kautzky-WillerA. HarreiterJ. PaciniG. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus.Endocr. Rev.201637327831610.1210/er.2015‑1137 27159875
     [Google Scholar]
  13. LandechoM.F. TueroC. ValentíV. BilbaoI. de la HigueraM. FrühbeckG. Relevance of leptin and other adipokines in obesity-associated cardiovascular risk.Nutrients20191111266410.3390/nu11112664 31694146
     [Google Scholar]
  14. XuG. YouD. WongL. Risk of all-cause and CHD mortality in women versus men with type 2 diabetes: A systematic review and meta-analysis.Eur. J. Endocrinol.2019180424325510.1530/EJE‑18‑0792 30668524
     [Google Scholar]
  15. El KhoudaryS.R. AggarwalB. BeckieT.M. Menopause transition and cardiovascular disease risk: Implications for timing of early prevention: A scientific statement from the american heart association.Circulation202014225e506e53210.1161/CIR.0000000000000912 33251828
     [Google Scholar]
  16. XiangD. LiuY. ZhouS. ZhouE. WangY. Protective effects of estrogen on cardiovascular disease mediated by oxidative stress.Oxid. Med. Cell. Longev.2021202111510.1155/2021/5523516 34257804
     [Google Scholar]
  17. ReslanO.M. KhalilR.A. Vascular effects of estrogenic menopausal hormone therapy.Rev. Recent Clin. Trials201271477010.2174/157488712799363253 21864249
     [Google Scholar]
  18. DeanfieldJ.E. HalcoxJ.P. RabelinkT.J. Endothelial function and dysfunction: Testing and clinical relevance.Circulation2007115101285129510.1161/CIRCULATIONAHA.106.652859 17353456
     [Google Scholar]
  19. MurphyE. Estrogen signaling and cardiovascular disease.Circ. Res.2011109668769610.1161/CIRCRESAHA.110.236687 21885836
     [Google Scholar]
  20. AltabasV. Diabetes, endothelial dysfunction, and vascular repair: What should a diabetologist keep his eye on?Int. J. Endocrinol.2015201511410.1155/2015/848272 26089898
     [Google Scholar]
  21. HuangE.S. LaiteerapongN. LiuJ.Y. JohnP.M. MoffetH.H. KarterA.J. Rates of complications and mortality in older patients with diabetes mellitus: The diabetes and aging study.JAMA Intern. Med.2014174225125810.1001/jamainternmed.2013.12956 24322595
     [Google Scholar]
  22. AmeliaR. HarahapJ. YunandaY. WijayaH. FujiatiI.I. YamamotoZ. Early detection of macrovascular complications in type 2 diabetes mellitus in Medan, North Sumatera, Indonesia: A cross-sectional study.F1000 Res.20211080810.12688/f1000research.54649.1
     [Google Scholar]
  23. KaurR. KaurM. SinghJ. Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: Molecular insights and therapeutic strategies.Cardiovasc. Diabetol.201817112110.1186/s12933‑018‑0763‑3 30170601
     [Google Scholar]
  24. ChentliF. AzzougS. MahgounS. Diabetes mellitus in elderly.Indian J. Endocrinol. Metab.201519674475210.4103/2230‑8210.167553 26693423
     [Google Scholar]
  25. NanayakkaraN. CurtisA.J. HeritierS. Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: Systematic review and meta-analyses.Diabetologia202164227528710.1007/s00125‑020‑05319‑w 33313987
     [Google Scholar]
  26. ThomasP.B. RobertsonD.H. ChawlaN.V. Predicting onset of complications from diabetes: A graph based approach.Appl. Netw. Sci.2018314810.1007/s41109‑018‑0106‑z 30581983
     [Google Scholar]
  27. AsifM. The prevention and control the type-2 diabetes by changing lifestyle and dietary pattern.J. Educ. Health Promot.201431110.4103/2277‑9531.127541 24741641
     [Google Scholar]
  28. Galicia-GarciaU. Benito-VicenteA. JebariS. Pathophysiology of type 2 diabetes mellitus.Int. J. Mol. Sci.20202117627510.3390/ijms21176275 32872570
     [Google Scholar]
  29. GiriB. DeyS. DasT. SarkarM. BanerjeeJ. DashS.K. Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: An update on glucose toxicity.Biomed. Pharmacother.201810730632810.1016/j.biopha.2018.07.157 30098549
     [Google Scholar]
  30. HamdyO. Abou-EleninK. LoGerfoF.W. HortonE.S. VevesA. Contribution of nerve-axon reflex-related vasodilation to the total skin vasodilation in diabetic patients with and without neuropathy.Diabetes Care200124234434910.2337/diacare.24.2.344 11213890
     [Google Scholar]
  31. AngL. JaiswalM. MartinC. Pop-BusuiR. Glucose control and diabetic neuropathy: Lessons from recent large clinical trials.Curr. Diab. Rep.201414952810.1007/s11892‑014‑0528‑7 25139473
     [Google Scholar]
  32. LuY. XingP. CaiX. Prevalence and risk factors for diabetic peripheral neuropathy in type 2 diabetic patients from 14 countries: Estimates of the INTERPRET-DD study.Front. Public Health2020853437210.3389/fpubh.2020.534372 33194943
     [Google Scholar]
  33. DarivemulaS. NagoorK. PatanS.K. ReddyN.B. DeepthiC.S. ChittooruC.S. Prevalence and its associated determinants of diabetic peripheral neuropathy (DPN) in individuals having type-2 diabetes mellitus in rural South India.Indian J. Community Med.2019442889110.4103/ijcm.IJCM_207_18 31333282
     [Google Scholar]
  34. AmourA.A. ChambaN. KayandabilaJ. Prevalence, patterns, and factors associated with peripheral neuropathies among diabetic patients at tertiary hospital in the Kilimanjaro Region: Descriptive cross-sectional study from North-Eastern Tanzania.Int. J. Endocrinol.201920191710.1155/2019/5404781 31275374
     [Google Scholar]
  35. SendiR. MahrusA. SaeedR. MohammedM. Al-DubaiS.R. Diabetic peripheral neuropathy among Saudi diabetic patients: A multicenter cross-sectional study at primary health care setting.J. Family Med. Prim. Care20209119720110.4103/jfmpc.jfmpc_927_19 32110590
     [Google Scholar]
  36. American Diabetes AssociationStandards of Medical Care in Diabetes—2022 Abridged for Primary Care Providers.Clin. Diabetes2022401103810.2337/cd22‑as01 35221470
     [Google Scholar]
  37. ZorenaK. Jachimowicz-DudaO. ŚlęzakD. RobakowskaM. MrugaczM. Adipokines and Obesity. Potential Link to Metabolic Disorders and Chronic Complications.Int. J. Mol. Sci.20202110357010.3390/ijms21103570 32443588
     [Google Scholar]
  38. MenendezA. WanczykH. WalkerJ. ZhouB. SantosM. FinckC. Obesity and adipose tissue dysfunction: From pediatrics to adults.Genes (Basel)20221310186610.3390/genes13101866 36292751
     [Google Scholar]
  39. ObradovicM. Sudar-MilovanovicE. SoskicS. Leptin and obesity: Role and clinical implication.Front. Endocrinol. (Lausanne)20211258588710.3389/fendo.2021.585887 34084149
     [Google Scholar]
  40. KumarR. MalK. RazaqM.K. Association of leptin with obesity and insulin resistance.Cureus20201212e1217810.7759/cureus.12178 33489589
     [Google Scholar]
  41. RehmanK. AkashM.S.H. Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked?J. Biomed. Sci.20162318710.1186/s12929‑016‑0303‑y 27912756
     [Google Scholar]
  42. Al-MansooriL. Al-JaberH. PrinceM.S. ElrayessM.A. Role of inflammatory cytokines, growth factors and adipokines in adipogenesis and insulin resistance.Inflammation2022451314410.1007/s10753‑021‑01559‑z 34536157
     [Google Scholar]
  43. TsiotraP.C. BoutatiE. DimitriadisG. RaptisS.A. High insulin and leptin increase resistin and inflammatory cytokine production from human mononuclear cells.BioMed Res. Int.2013201311010.1155/2013/487081 23484124
     [Google Scholar]
  44. AmeliaR. HarahapJ. WijayaH. The role of physical activity on glucose transporter-4, fasting blood glucose level and glycate hemoglobin in type 2 diabetes mellitus patients in Medan, Indonesia.Family Medicine & Primary Care Review202123327427810.5114/fmpcr.2021.108188
     [Google Scholar]
  45. JendeJ.M.E. GroenerJ.B. RotherC. Association of serum cholesterol levels with peripheral nerve damage in patients with type 2 diabetes.JAMA Netw. Open201925e19479810.1001/jamanetworkopen.2019.4798 31150078
     [Google Scholar]
  46. KollmerJ. BendszusM. Magnetic resonance neurography: Improved diagnosis of peripheral neuropathies.Neurotherapeutics20211842368238310.1007/s13311‑021‑01166‑8 34859380
     [Google Scholar]
  47. MorofujiY. NakagawaS. UjifukuK. Beyond lipid-lowering: Effects of statins on cardiovascular and cerebrovascular diseases and cancer.Pharmaceuticals (Basel)202215215110.3390/ph15020151 35215263
     [Google Scholar]
  48. GiuglianoR.P. PedersenT.R. SaverJ.L. Stroke prevention with the PCSK9 (proprotein convertase subtilisin-kexin type 9) inhibitor evolocumab added to statin in high-risk patients with stable atherosclerosis.Stroke20205151546155410.1161/STROKEAHA.119.027759 32312223
     [Google Scholar]
  49. YangC.P. LinC.C. LiC.I. Cardiovascular risk factors increase the risks of diabetic peripheral neuropathy in patients with type 2 diabetes mellitus.Medicine (Baltimore)20159442e178310.1097/MD.0000000000001783 26496307
     [Google Scholar]
  50. SuJ. ZhaoL. ZhangX. HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients.Cardiovasc. Diabetol.20181714710.1186/s12933‑018‑0693‑0 29598819
     [Google Scholar]
  51. ZhouZ. SunB. HuangS. ZhuC. BianM. Glycemic variability: adverse clinical outcomes and how to improve it?Cardiovasc. Diabetol.202019110210.1186/s12933‑020‑01085‑6 32622354
     [Google Scholar]
  52. SherwaniSI KhanHA EkhzaimyA MasoodA SakharkarMK Significance of HbA1c test in diagnosis and prognosis of diabetic patients.Biomark Insights201611BMI.S3844010.4137/BMI.S38440 27398023
     [Google Scholar]
  53. ElbarshaA. HamedhM. ElsaeitiM. Prevalence and risk factors of diabetic peripheral neuropathy in patients with Type 2 diabetes mellitus.Ibnosina J Med BiomedSci2019111252810.4103/ijmbs.ijmbs_3_19
     [Google Scholar]
  54. CasadeiG. FilippiniM. BrognaraL. Glycated hemoglobin (HbA1c) as a biomarker for diabetic foot peripheral neuropathy.Diseases2021911610.3390/diseases9010016 33671807
     [Google Scholar]
  55. BahadoranZ. MirmiranP. GhasemiA. Role of nitric oxide in insulin secretion and glucose metabolism.Trends Endocrinol. Metab.202031211813010.1016/j.tem.2019.10.001 31690508
     [Google Scholar]
  56. FörstermannU SessaWC Nitric oxide synthases: regulation and function.Eur Heart J2012337829-837, 837a-837d10.1093/eurheartj/ehr304 21890489
     [Google Scholar]
  57. GambardellaJ. KhondkarW. MorelliM.B. WangX. SantulliG. TrimarcoV. Arginine and endothelial function.Biomedicines20208827710.3390/biomedicines8080277 32781796
     [Google Scholar]
  58. ShibuyaM. Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: A crucial target for anti- and pro-angiogenic therapies.Genes Cancer20112121097110510.1177/1947601911423031 22866201
     [Google Scholar]
  59. QuattriniC. JeziorskaM. BoultonA.J.M. MalikR.A. Reduced vascular endothelial growth factor expression and intra-epidermal nerve fiber loss in human diabetic neuropathy.Diabetes Care200831114014510.2337/dc07‑1556 17934147
     [Google Scholar]
  60. AmeliaR. Sari WahyuniA. YunandaY. WijayaH. Atherosclerotic cardiovascular disease in diabetes patients.Curr. Diabetes Rev.2023198e06022321345710.2174/1573399819666230206124638 36748224
     [Google Scholar]
  61. AmeliaR. WijayaH. RusdianaR. WidjajaS. Risk of cardiovascular complication among type 2 diabetes mellitus patients in medan, Indonesia. A Cross-sectional Study.Med. Arh.202276532432810.5455/medarh.2022.76.324‑328 36545452
     [Google Scholar]
  62. AmeliaR. HarahapJ. Zulham, Fujiati II, Wijaya H. Educational model and prevention on prediabetes: A systematic review.Curr. Diabetes Rev.2024206e10102322194510.2174/0115733998275518231006074504 37818560
     [Google Scholar]
/content/journals/cdr/10.2174/0115733998297210240325062747
Loading
Early Detection of Diabetic Peripheral Neuropathy in Diabetic Patients: A Cross-Sectional Study
Curr. Diabetes Rev. 21, E280324228439 (2025); https://doi.org/10.2174/0115733998297210240325062747
/content/journals/cdr/10.2174/0115733998297210240325062747
/content/journals/cdr/10.2174/0115733998297210240325062747
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): chronic complications; Diabetes mellitus; diabetic peripheral neuropathy; nitric oxide; plasma blood glucose (PBG); VEGF

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test